Following Q2 Beat, Sarepta Has A Key Catalyst Coming In Q4
July 20, 2017 at 11:20 AM EDT
Sarepta Therapeutics Inc (NASDAQ: SRPT) is trading up more than 20 percent Thursday after a second-quarter beat that included $35 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.